2,3-dihydroxybenzoic acid has been researched along with 3,4-dihydroxyphenylpropionic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Günzler, V; Hanauske-Abel, HM; Kivirikko, KI; Majamaa, K; Myllylä, R | 1 |
Bora-Tatar, G; Dalkara, S; Dayangaç-Erden, D; Demir, AS; Erdem-Yurter, H; Yelekçi, K | 1 |
Al-Asri, J; Fazekas, E; Görick, C; Gyémánt, G; Lehoczki, G; Melzig, MF; Mortier, J; Perdih, A; Wolber, G | 1 |
Aoki, R; Asakura, T; Ezcurra, M; Goshima, Y; Ibi, M; Iino, Y; Kajihara, Y; Kanai, Y; Misu, Y; Miyamae, T; Mori, I; Nakamura, F; Ogura, K; Sasakura, H; Schafer, WR; Yagami, T | 1 |
4 other study(ies) available for 2,3-dihydroxybenzoic acid and 3,4-dihydroxyphenylpropionic acid
Article | Year |
---|---|
Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase.
Topics: Animals; Ascorbic Acid; Binding Sites; Chick Embryo; Ketoglutaric Acids; Kinetics; Phenols; Procollagen-Proline Dioxygenase; Protein Binding; Structure-Activity Relationship; Substrate Specificity | 1986 |
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
Topics: Caffeic Acids; Carboxylic Acids; Catalytic Domain; Chlorogenic Acid; Curcumin; Enzyme Inhibitors; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Models, Molecular; Molecular Structure; Protein Binding | 2009 |
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
Topics: alpha-Amylases; Carbohydrates; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2015 |
A seven-transmembrane receptor that mediates avoidance response to dihydrocaffeic acid, a water-soluble repellent in Caenorhabditis elegans.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Animals, Genetically Modified; Behavior, Animal; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Caffeic Acids; Catechols; Cloning, Molecular; Dose-Response Relationship, Drug; Escape Reaction; Hydroxybenzoates; Larva; Luminescent Proteins; Membrane Potentials; Microinjections; Models, Molecular; Mutation; Receptors, G-Protein-Coupled; Sensory Receptor Cells; Xenopus | 2011 |